Definition and risk factors of rapidly declining residual renal function in peritoneal dialysis: An observational study

Kidney and Blood Pressure Research

Volumn 35, Issue 4, 2012, Pages 233-241

  Herget Rosenthal, Stefan ^a,b   Von Ostrowski, Michael ^a   Kribben, Andreas ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Rotes Kreuz Krankenhaus   (Germany)

Author keywords

End stage renal disease; Glomerular filtration rate; Peritoneal dialysis; Residual renal function; Risk factors; Urine output

Indexed keywords

AMINOGLYCOSIDE; CONTRAST MEDIUM; ICODEXTRIN; NONSTEROID ANTIINFLAMMATORY AGENT; VANCOMYCIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFECTION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RESIDUAL RENAL FUNCTION; SEX DIFFERENCE; URINE VOLUME;

ADULT; AGED; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84855365330     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000332887     Document Type: Article

References (37)

1. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158-2162.
2. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320.
3. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-1302.
4. Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF, Li PK, Woo J: Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001; 12: 2450-2457.
5. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG: Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 2001; 16: 2207-2213.
6. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B: Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 2003; 18: 590-597.
7. Rodriguez-Carmona A, Perez-Fontan M, Garcia-Naveiro R, Villaverde P, Peteiro J: Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44: 132-145.
8. Hufnagel G, Michel C, Queffeulou G, Skhiri H, Danmieri H, Mignon F: The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 1999; 14: 1224-1228.
9. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, Gerlag PG, Hoorntje SJ, Wolters J, van der Sande FM, Leunissen KM: Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: A randomized study. Kidney Int 2003; 63: 1556-1563.
10. Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H: Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 2004; 43: 1056-1064.
11. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC: Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. Ann Intern Med 2003; 139: 105-112.
12. Caravaca F, Dominguez C, Arrobas M: Predictors of loss of residual renal function in peritoneal dialysis. Perit Dial Int 2002; 22: 414-417.
13. Haag-Weber M, Krämer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R: Low-GDP fluid attenuates decline of residual renal function in PD patients: A prospective randomized study. Nephrol Dial Transplant 2010; 25: 2288-2296.
14. Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, Oh KH: Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: A 1-year study. Nephrol Dial Transplant 2009; 24: 2899-2908.
15. Shin SK, Noh H, Kang SW, Seo BJ, Lee IH, Song HY, Choi KH, Ha SK, Lee HY, Han DS: Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19: 138-142.
16. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG: Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 2000; 20: 429-438.
17. Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 1999; 34: 14-20.
18. Dittrich E, Puttinger H, Schillinger M, Lang I, Stefenelli T, Hörl WH, Vychytil A: Effect of radiocontrast media on residual renal function in peritoneal dialysis patients - A prospective study. Nephrol Dial Transplant 2006; 21: 1334-1339.
19. Baker RJ, Senior H, Clemenger M, Brown EA: Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 2003; 41: 670-675.
20. Moranne O, Willoteaux S, Pagniez D, Dequiedt P, Boulanger E: Effect of iodinated contrast agents on residual renal function in PD patients. Nephrol Dial Transplant 2006; 21: 1040-1045.
21. Holley JL, Aslam N, Bernardini J, Fried L, Piraino B: The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients. Perit Dial Int 2001; 21: 302-305.
22. Lui SL, Cheng SW, Ng F, Ng SY, Wan KM, Yip T, Tse KC, Lam MF, Lai KN, Lo WK: Cefazolin plus netilmecin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 2005; 68: 2375-2380.
23. Cnossen TT, Usvyat L, Kotanko P, van der Sande FM, Kooman JP, Carter M, Leunissen KM, Levin NW: Comparison of outcomes on continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis: results from a USA database. Perit Dial Int 2010 (Epub ahead of print).
24. Balasubramanian G, McKitty K, Fan SL: Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences? Nephrol Dial Transplant 2011; 26: 1702-1708.
25. Fan S.L, Pile T, Punzalan S, Raftery MJ, Yaqoob MM: Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008; 73: 200-206.
26. Schiffl H, Mucke C, Lang SM: Rapid decline of residual renal function in patients with late renal transplant failure who are re-treated with CAPD. Perit Dial Int 2003; 23: 398-400.
27. Bernardo A, Fonseca I, Rodrigues A, Carvalho MJ, Cabrita A: Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor? Adv Perit Dial 2009; 25: 110-114.
28. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556-564.
29. Kolesnyk I, Noordzij M, Dekker FW, Boeschoeten EW, Krediet RT: Treatment with angiotensin II inhibitors and residual renal function in peritoneal dialysis patients. Perit Dial Int 2011; 31: 53-59.
30. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG: Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002; 13: 2125-2132.
31. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM: Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415-418.
32. ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
33. Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, Chuang HF, Hung KY, Wu KD, Tsai TJ: Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on longterm peritoneal dialysis. Nephrol Dial Transplant 2009; 24: 2909-2914.
34. Davies SJ: Peritoneal dialysis in the patient with a failing renal allograft. Perit Dial Int 2001; 21(suppl 3):S280-S284.
35. Jassal SV, Lok CE, Walele A, Bargman JM: Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. Am J Kidney Dis 2002; 40: 178-183.
36. Weisbord SD, Bernardini J, Mor MK, Hartwig KC, Nicoletta PJ, Palevsky PM, Piraino B: The effect of coronary angiography on residual renal function in patients on peritoneal dialysis. Clin Cardiol 2006; 29: 494-497.
37. Qi H, Xu C, Yan H, Ma J: Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: A meta-analysis of randomized controlled trials. Perit Dial Int 2011; 31: 179-188.